Is Response to Prophylactic Lithium a Familial Trait?
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Selecting a drug according to the treatment response in a relative has been widely accepted advice in the management of mood disorders. However, this recommendation has not been adequately substantiated in the literature. We tested the hypothesis that response to long-term lithium treatment is a familial trait. METHOD: We compared response to long-term lithium treatment in bipolar relatives of bipolar lithium responders and bipolar controls. Twenty-four relatives with bipolar disorder (as determined using the Schedule for Affective Disorders and Schizophrenia-Lifetime version [SADS-L] and Research Diagnostic Criteria [RDC]) were identified in families of 106 patients with lithium-responsive bipolar disorder. A consecutive series of 40 lithium-treated patients in a bipolar clinic (meeting RDC and DSM-IV criteria for bipolar disorder) served as a comparison group. Lithium response was evaluated on a rating scale reflecting the quality and quantity of available data. RESULTS: The prevalence of unequivocal response among the relatives was 67%, as compared with the response rate of 35% in the comparison group (chi2 = 6.04, df = 1, p = .014). CONCLUSION: This highly significant difference in response between relatives and the control group supports the view that the response to lithium prophylaxis clusters in families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with a study showing that patients who have a lithium‐responsive relative have a 67% likelihood of also being lithium responsive, versus 35% of those without a responsive relative.417”
Citations
Cites
Research Diagnostic Criteria: Rationale and Reliability
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,951
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
Kaplan and Sadock's synopsis of psychiatry
Sadock, B. J., & Sadock, V. A. (1998) · Cited by 450
Relationship Between the Effectiveness of Lithium Therapy and Family History
MENDLEWICZ, J., FIEVE, R. R., & STALLONE, F. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.9.1011 · Cited by 166
DIFFERENTIATION OF TWO GENETICALLY SPECIFIC TYPES OF DEPRESSION BY THE RESPONSE TO ANTI-DEPRESSANTS
Pare, C. M. B., Rees, L., & Sainsbury, M. J. (1962) · The Lancet · doi:10.1016/s0140-6736(62)91019-x · Cited by 165
Does Lithium Treatment Still Work?: Evidence of Stable Responses Over Three Decades
Baldessarini, R. J., & Tondo, L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.187 · Cited by 164
Lithium response and genetics of affective disorders
Grof, P., Alda, M., Gror, E., Zvolsky, P., & Walsh, M. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90066-3 · Cited by 161
Self-citationFamilial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
Franchini, L., Serretti, A., Gasperini, M., & Smeraldi, E. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00004-1 · Cited by 156
Evidence for a role of phospholipase C-γ1 in the pathogenesis of bipolar disorder
Turecki, G., Grof, P., Cavazzoni, P. A., Duffy, A. C., Grof, E., Ahrens, B., Berghöfer, A., Müller-Oerlinghausen, B., Dvorakova, M. C., Libigerová, E., et al. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000447 · Cited by 127
Self-citationPharmacogenetic response to antidepressants in a multicase family with affective disorder
O’Reilly, R. L., Bogue, L., & Singh, S. M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90642-4 · Cited by 116
Cited by
Items 201–300 of 443
Pisanu, C., Congiu, D., Costa, M. F., Sestu, M., Chillotti, C., Ardau, R., Deiana, V., Manchia, M., Squassina, A., & Zompo, M. D. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.09.025 · Cited by 17
“Of the 357 patients, 204 were characterized for lithium response using the “Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder” as described previously (Grof et al., 2002).”
Saitô, S., Fujii, K., Ozeki, Y., Ohmori, K., Honda, G., Mori, H., Kato, K., Kuroda, J., Aoki, A., Asahi, H., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12521 · Cited by 16
Mini review: Recent advances on epigenetic effects of lithium
Marie-Claire, C., Étain, B., & Bellivier, F. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136116 · Cited by 22
Genetic and Epigenetic Markers of Lithium Response
Pisanu, C., Meloni, A., Severino, G., & Squassina, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031555 · Cited by 19
“Response to lithium was retrospectively assessed using the Alda Scale [7].”
BackgroundMethodIdemoto, K., Niitsu, T., Hata, T., Ishima, T., Yoshida, S., Hattori, K., Horai, T., Otsuka, I., Yamamori, H., Toda, S., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113967 · Cited by 15
Methylomic biomarkers of lithium response in bipolar disorder: a clinical utility study
Marie-Claire, C., Courtin, C., Bellivier, F., Gard, S., Leboyer, M., Scott, J. L., & Étain, B. (2023) · International Journal of Bipolar Disorders · doi:10.1186/s40345-023-00296-6 · Cited by 19
“Phenotyping of response to lithium Response to Li was rated using the “Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder”, also referred to as the “Alda scale” (Grof et al. 2002).”
MethodManchia, M., Paribello, P., Arzedi, C., Bocchetta, A., Caria, P., Cocco, C., Congiu, D., Cossu, E., Dettori, T., Frau, D. V., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032513 · Cited by 20
Methylomic Biomarkers of Lithium Response in Bipolar Disorder: A Proof of Transferability Study
Marie-Claire, C., Courtin, C., Bellivier, F., Scott, J. L., & Étain, B. (2022) · Pharmaceuticals · doi:10.3390/ph15020133 · Cited by 16
“The response to Li was rated using the “Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder”, also referred to as the “Alda scale” [27].”
MethodBeyond the Guidelines for Bipolar Disorder: Practical Issues in Long-Term Treatment with Lithium
Calkin, C., & Alda, M. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700707 · Cited by 15
Self-citationMenculini, G., Steardo, L., Verdolini, N., D’Angelo, M., Chipi, E., Cirimbilli, F., Orsolini, L., Volpe, U., Fazio, P. D., & Tortorella, A. A. V. (2023) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2022.2160763 · Cited by 13
“A score 7 underpins good response, a score from 4 to 6 a moderate response, and a score of 3 a poor response (Grof et al., 2002; Manchia et al., 2013).”
BackgroundRecommendations for defining treatment outcomes in major psychiatric disorders using real-world data
Koch, E. M., Smart, S. E., Einarsson, G., Kämpe, A. J., Jönsson, L., Alver, M., Iveson, M. H., Göteson, A., Pardiñas, A. F., Sønderby, I. E., et al. (2025) · The Lancet Psychiatry · doi:10.1016/s2215-0366(25)00061-6 · Cited by 17
Can actigraphy be used to define lithium response dimensions in bipolar disorders?
Étain, B., Meyrel, M., Hennion, V., Bellivier, F., & Scott, J. L. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.01.060 · Cited by 15
Clinical Handbook for the Diagnosis and Treatment of Pediatric Mood Disorders
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200 · Cited by 14
Piguel, N. H., Sanders, S. S., Simone, F. I. D., Martin‐de‐Saavedra, M. D., McCoig, E., Dionisio, L. E., Smith, K. R., Thomas, G. M., & Penzes, P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1144066 · Cited by 16
“Responsiveness of BD patients to lithium treatment appears to be a heritable trait (Grof et al., 2002) linked to genetic markers in patients isolated from GWAS (Hou et al.”
BackgroundAssessing treatment response to prophylactic lithium use in patients with bipolar disorder
Silva, L. F. D. A. L. E., Loureiro, J. C., Franco, S. C. R., Santos, M. D. L., Secolin, R., Lopes‐Cendes, Í., Dantas, C. D. R., & Banzato, C. E. M. (2016) · Jornal Brasileiro de Psiquiatria · doi:10.1590/0047-2085000000097 · Cited by 14
Pharmacotherapeutic strategies for pediatric bipolar disorder
Madaan, V., & Chang, K. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.12.1801 · Cited by 16
“It has been reported that ∼ 40 – 50% of children and adolescents with bipolar disorder respond acutely to lithium alone [33,44,45] .”
BackgroundCattane, N., Courtin, C., Mombelli, E., Maj, C., Mora, C., Étain, B., Bellivier, F., Marie-Claire, C., & Cattaneo, A. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04286-3 · Cited by 16
“Subjects with ALDA score ≥ 7 are classified as “responders”, whereas those with ALDA score < 7 represent “non-responders” [50].”
BackgroundMicroRNAs as potential diagnostic biomarkers for bipolar disorder
Martinez, B., & Peplow, P. V. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01588 · Cited by 16
“The patient’s response to lithium treatment was determined according to the Lithium Treatment Response Scale (the Alda scale) (Grof et al., 2002).”
Montlahuc, C., Curis, E., Laroche, D. G., Bagoe, G., Étain, B., Bellivier, F., & Chevret, S. (2018) · Pharmacopsychiatry · doi:10.1055/s-0044-100521 · Cited by 13
“Pharmacopsychiatry 2019; 52: 70–77 evaluation and about the quantification of the response (time to event [18], probability of the event [4, 19], and continuous quantification [20]).”
BackgroundPiguel, N. H., Yoon, S., Gao, R., Horan, K. E., Garza, J. C., Petryshen, T. L., Smith, K. R., & Penzes, P. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01502-2 · Cited by 17
“The responsiveness of BD patients to lithium treatment appears to be a heritable trait [23] linked to genetic markers in patients as evidenced in GWAS [24, 25].”
BackgroundLee, J., Baek, J. H., Lee, D., Ahn, S. W., Yang, S., Choi, Y., Bahk, Y. C., & Hong, K. S. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-020-00199-w · Cited by 19
History Repeats Itself: The Family Medication History and Pharmacogenomics
Smith, T. R., Kearney, E., Hulick, P. J., & Kisor, D. F. (2016) · Pharmacogenomics · doi:10.2217/pgs-2015-0015 · Cited by 12
Pharmacogenetics of mood disorders: what clinicians need to know
Laje, G. (2013) · CNS Spectrums · doi:10.1017/s1092852913000278 · Cited by 15
Tye, S. J., Borreggine, K. L., Price, J. B., Sutor, S. L., Barboza, A. B. C., McElroy, S. L., Biernacka, J. M., & Frye, M. A. (2021) · Bipolar Disorders · doi:10.1111/bdi.13081 · Cited by 12
Lithium long-term treatment in mood disorders: clinical and genetic predictors
Serretti, A. (2002) · Pharmacogenomics · doi:10.1517/14622416.3.1.117 · Cited by 12
Translating knowledge of genetics and pharmacology into improving everyday practice
Yatham, L. N. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00211.x · Cited by 12
Ancestry component as a major predictor of lithium response in the treatment of bipolar disorder
Díaz‐Zuluaga, A. M., Velez, J. I., Arias, J. M. C., Valencia‐Echeverry, J., Castano, M., Palacio, J. D., Arcos‐Burgos, M., & López‐Jaramillo, C. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.03.058 · Cited by 11
Duffy, A. C., & Grof, P. (2024) · International Journal of Bipolar Disorders · doi:10.1186/s40345-024-00333-y · Cited by 17
“The responsiveness to a particular type of mood stabilizer was also observed to breed true or cluster in families (Grof et al. 2002).”
BackgroundSelf-citationRNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers
Pisanu, C., & Squassina, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210067 · Cited by 14
“However, clinical response to lithium presents a high interindividual variability, with approximately 70% of patients showing partial or nonresponse [4].”
BackgroundResultMusetti, L., Tundo, A., Benedetti, A., Massimetti, G., Cambiali, E., Pergentini, I., Grande, C. D., & Dell’Osso, L. (2018) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2676 · Cited by 11
Neurobiology of Mood Disorders
Manchia, M., & Schatzberg, A. F. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_83 · Cited by 11
Familial traits of bipolar disorder: A systematic review and meta‐analysis
Scott, K., Nunes, A., Pavlová, B., Meier, S. M., & Alda, M. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13569 · Cited by 13
Self-citationMoreira, J., Courtin, C., Geoffroy, P. A., Curis, E., Bellivier, F., & Marie-Claire, C. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.022 · Cited by 10
Mamdani, F., Groisman, I. J., Alda, M., & Turecki, G. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0088-z · Cited by 10
Self-citationInvolvement of core clock genes in lithium response
Pisanu, C., Congiu, D., Melis, C., Severino, G., Angius, A., Ardau, R., Chillotti, C., Zompo, M. D., & Squassina, A. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1346281 · Cited by 10
“Patients were selected retrospectively from a larger sample of BD patients characterised for lithium response using the Alda scale (Grof et al. 2002; Manchia et al. 2013) as in Geoffroy et al.”
MethodYeom, J. W., Yoon, Y., Seo, J. Y., Cho, C., Lee, T., Lee, J.-B., Jeon, S., Kim, L., & Lee, H. (2024) · Psychiatry Investigation · doi:10.30773/pi.2024.0133 · Cited by 10
Meloni, A., Paribello, P., Pinna, M., Contu, M., Ardau, R., Chillotti, C., Congiu, D., Gennarelli, M., Minelli, A., Buson, L., et al. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.10.012 · Cited by 11
Prediction of Treatment Outcome in Bipolar Disorder: When Can We Expect Clinical Relevance?
Scott, K., Khayachi, A., Alda, M., & Nunes, A. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.02.005 · Cited by 10
Self-citationThe Management of Prodromal Symptoms of Bipolar Disorder: Available Options and Future Perspectives
Favero, E. D., Montemagni, C., Bozzatello, P., Brasso, C., Riccardi, C., & Rocca, P. (2021) · Medicina · doi:10.3390/medicina57060545 · Cited by 12
Janiri, D., Simonetti, A., Luciano, M., Montanari, S., Bernardi, E., Carrà, G., Fiorillo, A., & Sani, G. (2024) · International Journal of Bipolar Disorders · doi:10.1186/s40345-024-00331-0 · Cited by 10
“A potential means to address this challenge lies in the systematic application of the ‘Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder,’ commonly known as the Alda scale (Grof et al. 2002).”
BackgroundGarcía, S., Gorostegi-Anduaga, I., García-Corres, E., Maldonado‐Martín, S., MacDowell, K. S., Ampudia, C. B., Apodaca, M. J., Pérez-Landaluce, I., Larrea, I. T., Leza, J. C., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.568455 · Cited by 10
“Subjects with Bipolar Disorder (Alda scale) (56).”
Pharmacogenetics of bipolar disorder
Mansour, H., Alda, M., & Nimgaonkar, V. L. (2002) · Current Psychiatry Reports · doi:10.1007/s11920-002-0044-3 · Cited by 9
Self-citationInterventions for Youth at Risk of Bipolar Disorder
Duffy, A. C. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-013-0006-x · Cited by 11
Self-citationGoldberg, J. F. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20190005 · Cited by 12
Scott, K., O’Donovan, C., Brancati, G. E., Cervantes, P., Ardau, R., Manchia, M., Severino, G., RYBAKOWSKI, J. K., Tondo, L., Grof, P., et al. (2024) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13692 · Cited by 9
“41 In addition, lithium response is familial in nature, 42 and ongoing research continues to identify contributing genetic variants.”
BackgroundSelf-citationLee, H., Han, D., Hong, K. S., Ha, K., Kim, H., Cho, E. Y., Myung, W., Rhee, S. J., Kim, J., Ha, T. H., et al. (2024) · International Journal of Bipolar Disorders · doi:10.1186/s40345-024-00342-x · Cited by 11
“The Alda scale, initially devised to gauge the response to lithium treatment in patients with bipolar disorders (Scott et al. 2020; Grof et al. 2002), has subsequently shown utility in assessing the treatment response of various medications, including valproate, thus reflecting real-world clinical…”
BackgroundThe St. Göran Project: A Multipronged Strategy for Longitudinal Studies for Bipolar Disorders
Landén, M., Jönsson, L., Klahn, A. L., Kardell, M., Göteson, A., Abé, C., Aspholmer, A., Liberg, B., Pelanis, A., Sparding, T., et al. (2025) · Neuropsychobiology · doi:10.1159/000543335 · Cited by 11
“Finally, lithium response was measured using the Retrospective Assessment of the Lithium Response Phenotype Scale (Alda scale) [33].”
Pharmacogenomics and response to lithium in bipolar disorder
Paribello, P., Isayeva, U., Pisanu, C., Squassina, A., & Manchia, M. (2024) · Pharmacogenomics · doi:10.1080/14622416.2025.2470605 · Cited by 9
High Familial Correlation in Methylphenidate Response and Side Effect Profile
Gazer-Snitovsky, M., Brand‐Gothelf, A., Dubnov‐Raz, G., Weizman, A., & Gothelf, D. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715580844 · Cited by 9
Early intervention in bipolar disorders: Where we are now and need to go next
Duffy, A. C. (2018) · Bipolar Disorders · doi:10.1111/bdi.12599 · Cited by 8
Self-citationLithium continuation for a patient with bipolar disorder and chronic kidney disease
Singh, B., Núñez, N. A., Schock, L., Joseph, B., Kohoutek, B., & Roerig, J. L. (2020) · Bipolar Disorders · doi:10.1111/bdi.12909 · Cited by 8
Tighe, S. K., Ritchey, M., Schweizer, B. W., Goes, F. S., MacKinnon, D. F., Mondimore, F. M., DePaulo, J. R., McMahon, F. J., Schulze, T. G., Zandi, P. P., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.021 · Cited by 8
El estudio Andalusian Bipolar Family (ABiF): protocolo y descripción de la muestra
Parra, J. G., Rivas, F., Strohmaier, J., Forstner, A. J., Streit, F., Auburger, G. W. J., Propping, P., Díaz, G. O., González, M. J., Flores, S. G., et al. (2017) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2017.03.004 · Cited by 7
Prediction of Response to Drug Therapy in Psychiatric Disorders
Stern, S., Linker, S. B., Vadodaria, K. C., Marchetto, M. C., & Gage, F. H. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.17304 · Cited by 8
Mapping the Cerebrospinal Fluid Proteome in Bipolar Disorder
Göteson, A., Holmén‐Larsson, J., Celik, H., Pelanis, A., Sellgren, C. M., Sparding, T., Pålsson, E., Zetterberg, H., Blennow, K., Jönsson, L., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.01.007 · Cited by 10
Laliberté, V., Yu, C., & Rej, S. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140359 · Cited by 9
Clark, S. R., Schubert, K. O., Olagunju, A. T., Lyrtzis, E., & Baune, B. T. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00662 · Cited by 6
“The Lifetime Psychotropic Treatment Response scale (LPTR) was modified from the Lithium Lifetime Treatment Response scale (LLTR) (43).”
BackgroundMethodInfluentialKang, Y.-W., Sun, T. H., Kim, G.-Y., Jung, H.-Y., Kim, H.-J., Lee, S., Park, Y. R., Tu, J., Lee, J.-H., Choi, K., et al. (2022) · Psychiatry Investigation · doi:10.30773/pi.2022.0102 · Cited by 6
Personalized medicine in bipolar disorder: how can we overcome the barriers to clinical translation?
Squassina, A., & Pisanu, C. (2013) · Personalized Medicine · doi:10.2217/pme.13.86 · Cited by 7
Pharmacogenetics and mood stabilization in bipolar disorder
Růžičková, M., Turecki, G., & Alda, M. (2003) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.20010 · Cited by 7
Self-citationAmare, A. T., Thalamuthu, A., Schubert, K. O., Fullerton, J. M., Ahmed, M. B., Hartmann, S., Papiol, S., Heilbronner, U., Degenhardt, F., Ayele, F. T., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2580252/v1 · Cited by 7
Self-citationGenetics and Antiepileptic Mood Stabilizer Treatment Response in Bipolar Disorder: What do we Know?
Ho, A. M., Weinshilboum, R. M., Frye, M. A., & Biernacka, J. M. (2021) · Pharmacogenomics · doi:10.2217/pgs-2021-0041 · Cited by 7
Cocco, C., Noli, B., Manconi, B., Contini, C., Manca, E., Pisanu, C., Meloni, A., Manchia, M., Paribello, P., Chillotti, C., et al. (2024) · Neuropsychobiology · doi:10.1159/000540673 · Cited by 6
“Response to lithium or valproic was characterised using the Retrospective Criteria of Long-Term Treatment Response in Research Subjects with BD scale (or ALDA scale) [33 – 35].”
Hayes, J., Abdesslem, F. B., Eloranta, S., Osborn, D., & Boman, M. (2024) · PeerJ · doi:10.7717/peerj.17841 · Cited by 6
“We believe this is a close approximation of treatment response as de fi ned by the Alda Scale ( Grof et al., 2002 ) and used in previous studies predicting lithium response.”
Couffignal, C., Bertrand, J., Sportiche, S., Jarroir, M., Balkhi, S. E., Djebrani‐Oussedik, N., Poupon, J., Declèves, X., Mentré, F., & Bellivier, F. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2605-3 · Cited by 7
Scott, J. L., Lajnef, M., Icick, R., Bellivier, F., Cynthia Marie-claire, A., & Étain, B. (2021) · Pharmaceuticals · doi:10.3390/ph14111072 · Cited by 6
“clinical phenotypes of the Li response from ratings of the Retrospective Assessment of Response to Lithium Scale (usually referred to as the Alda scale) [13].”
MethodClinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder
Núñez, N. A., Coombes, B. J., Romo‐Nava, F., Bond, D. J., Voort, J. V., Croarkin, P. E., Leibman, N. I., Gardea‐Resendez, M., Veldić, M., Betcher, H. K., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.884217 · Cited by 10
“Treatment response to lithium, antipsychotics and antiepileptic mood stabilizers (lamotrigine and divalproex) were assessed with the Alda scale (20).”
MethodSquassina, A., Meloni, A., Congiu, D., Bosganas, P., Patrinos, G. P., Lin, R., Turecki, G., Severino, G., Ardau, R., Chillotti, C., et al. (2022) · Human Genomics · doi:10.1186/s40246-022-00418-8 · Cited by 9
“Clinical response to maintenance treatment with lithium was evaluated using the “Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder” (Alda scale) [30, 31], as previously described [32].”
MethodFactors Affecting Time to Rehospitalization for Chinese Patients with Bipolar I Disorder in Taiwan
Lin, C., Kuo, C.-C., Liu, R.-Y., Huang, C., & Chen, C. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670903179145 · Cited by 7
Neurobiology and temperament in the offspring of excellent lithium responders
Ferensztajn‐Rochowiak, E., Skibińska, M., Kaczmarek, M., Losy, J., & RYBAKOWSKI, J. K. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.913810 · Cited by 6
“The scores obtained on these scales were correlated with the assessment of prophylactic lithium effi cacy by means of the Alda scale (Grof et al. 2002).”
MethodClinical response and metabolic effects of lithium in 323 mood disorder patients
Pinna, M., Manchia, M., Visioli, C., & Tondo, L. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.066 · Cited by 7
Yang, J. M. K., Jones, I. R., & Florio, A. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-91832-3_9 · Cited by 7
Gross, G., Tursini, K., Albuisson, É., Angioï-Duprez, K., Conart, J., Louis-Dorr, V., Schwan, R., & Schwitzer, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.960512 · Cited by 6
“Patients treated with lithium will complete the Alda Scale to assess response to treatment (44).”
MethodRodríguez‐Ramírez, A. M., Cedillo‐Ríos, V., Becerra‐Palars, C., Meza-Urzúa, F., Pavón, J. J., Morales-Cedillo, I. P., Lopez‐Titla, M. M., Sánchez-Segura, C. L., Martínez-Gudiño, M. D. L., Ortega‐Ortíz, H., et al. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111382 · Cited by 5
Selvarajan, S., Srinivasan, A., Sakkarabani, P., Verma, A., Rajendran, P., & Kandasamy, P. (2022) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2022.103018 · Cited by 5
Treatment of Bipolar Depression
Post, R. M., Baldassano, C. F., Perlis, R. H., & Ginsberg, D. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-435-7_5 · Cited by 5
Blower, P. J. (2003) · Annual Reports Section A (Inorganic Chemistry) · doi:10.1039/b211477c · Cited by 5
Voinsky, I., McCarthy, M. J., Shekhtman, T., Kelsoe, J. R., & Gurwitz, D. (2019) · Drug Development Research · doi:10.1002/ddr.21598 · Cited by 5
“Nonetheless, our study was performed with PBMC samples from wellphenotyped and longitudinally followed female BD patients, with records collected on number of mania episodes, presence of psychotic symptoms, disease severity, suicide attempts, alcohol dependence, seasonal pattern, and efficacy of lithium treatment rate…”
MethodInfluentialKendler, K. S., Ohlsson, H., Sundquist, J., & Sundquist, K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02365-9 · Cited by 6
“Treatment response to psychopharmacologic agents has previously been shown to run in families [1 – 3].”
Out-patient institutionalisation
Kontos, N. J., Freudenreich, O., & Querques, J. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.139790 · Cited by 4
Lithiumtherapie zur Behandlung affektiver Störungen im höheren Lebensalter
Christl, J., & Supprian, T. (2023) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-023-02164-5 · Cited by 6
“Hilfreich kann die Anwendung der Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder (ALDA-Skala; [2, 29]) sein.”
BackgroundStacey, D., Suppiah, V., Benyamin, B., Lee, S., & Hyppönen, E. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.050 · Cited by 4
Lee, Y., Lee, D., Jung, H., Cho, Y., Baek, J. H., & Hong, K. S. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04318-y · Cited by 5
“The long-term treatment response to mood stabilizers was evaluated using the Alda scale [20].”
MethodRodríguez‐Ramírez, A. M., Cedillo‐Ríos, V., Sanabrais‐Jiménez, M. A., Becerra‐Palars, C., Hernández, S., Ortega‐Ortíz, H., & Camarena, B. (2023) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32966 · Cited by 4
“Prior studies had associated genetic (Geoffroy et al., 2014; Grof, Duffy, Cavazzoni, 2002; Novák et al., 2011) and brain structural characteristics (Lyoo et al., 2010; Porcu et al., 2016; Zhang et al., 2018) with treatment response in BD, the combination of these research technologies might help to…”
BackgroundMethodIazzolino, A. M., Valenza, M., D’Angelo, M., Longobardi, G., Stefano, V. D., Luca, S., Scuderi, C., & Steardo, L. (2024) · International Journal of Bipolar Disorders · doi:10.1186/s40345-024-00330-1 · Cited by 6
“To do so we used the Alda scale, an 11-point rating scale (Grof et al. 2002) adapted to measure the response to mood stabilizers (Garnham et al. 2007; Steardo et al. 2019).”
MethodMoreira, J., Noé, G., Rangarajan, S., Courtin, C., Étain, B., Geoffroy, P. A., Laplanche, J., Vidal, M., Bellivier, F., & Cynthia Marie-claire, A. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1487078 · Cited by 4
“Long-term treatment response to lithium was evaluated using the validated scale ‘Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder’ also known as the Alda scale (Grof et al. 2002).”
MethodGenetics and psychopharmacology: prospects for individualized treatment.
Nnadi, C. U., Goldberg, J. F., & Malhotra, A. K. (2005) · PubMed · Cited by 4
Bipolar disorder in young people: Description, assessment and evidence-based treatment
Carr, A. (2009) · Developmental Neurorehabilitation · doi:10.3109/17518420903042454 · Cited by 10
“There is some evidence from family aggregation studies of bipolar adults that genetically homogeneous sub-groups may be delineated based on the presence of psychotic features [42], co-morbid panic attacks [43], puerperal status [44], age of onset [45] and responsivity to lithium [46].”
The Andalusian Bipolar Family (ABiF) Study: Protocol and sample description
Parra, J. G., Rivas, F., Strohmaier, J., Forstner, A. J., Streit, F., Auburger, G. W. J., Propping, P., Díaz, G. O., González, M. J., Flores, S. G., et al. (2018) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2017.03.003 · Cited by 4
Treatment of Bipolar Depression
Dunn, R. T., & Post, R. M. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-792-5_4 · Cited by 4
Psychiatric genetics — Does diagnosis matter?
Alda, M. (2017) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170146 · Cited by 4
Self-citationUlusoy, M., Başkak, B., Çakmak, I. B., Tok, K. C., & Suzen, H. S. (2025) · Chronobiology International · doi:10.1080/07420528.2025.2597961 · Cited by 3
“The Alda Scale is a clinical instrument used to assess the effectiveness of maintenance therapy in BD, incorporating both treatment outcomes and contextual clinical factors (Grof et al. 2002).”
BDNF Val66Met polymorphism and lithium response: a meta-analysis
Ehret, M. J., Baker, W. L., & O’Neill, H. (2013) · Personalized Medicine · doi:10.2217/pme.13.74 · Cited by 3
Investigating light sensitivity in bipolar disorder (HELIOS-BD)
Roguski, A., Needham, N., MacGillivray, T., Martinović, J., Dhillon, B., Riha, R. L., Armstrong, L., Campbell, I. H., Ferguson, A., Hilgen, G., et al. (2024) · Wellcome Open Research · doi:10.12688/wellcomeopenres.20557.1 · Cited by 5
A taxonomy of clinical response to mood stabilizers
Scott, J. L., Étain, B., Nierenberg, A. A., & Bellivier, F. (2020) · Bipolar Disorders · doi:10.1111/bdi.12950 · Cited by 4
Heilbronner, U., & Schulze, T. G. (2014) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2014.02.017 · Cited by 3
Pharmacogenetic aspects of bipolar disorder
Alda, M. (2003) · Pharmacogenomics · doi:10.1517/phgs.4.1.35.22584 · Cited by 3
Self-citationPharmacological Management of New-Onset Bipolar Disorder
Kratochvil, C. J., DelBello, M. P., Upadhyaya, H. P., & Wozniak, J. R. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000177057.49278.7b · Cited by 3
Personalized treatment in bipolar disorder
Salagre, E., Vieta, E., & Grande, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813176-3.00035-3 · Cited by 5
Future Directions in Genetics of Psychiatric Disorders
Wray, N. R., Byrne, E. M., Stringer, S., & Mowry, B. J. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9509-3_11 · Cited by 3
Metadata
- Authors
- Grof, P., Duffy, A., Cavazzoni, P., Grof, E., Garnham, J., MacDougall, M., O'Donovan, C., & Alda, M.
- Affiliations
- University of Ottawa (CA)
- Dalhousie University (CA)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-10-15
- Volume
- 63
- Issue
- 10
- Pages
- 942-947
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2136422355
- Semantic Scholar
- 5c8d39caedae6c6c21cb238faa737643cc7f8b07
- Cited by
- 438
- References
- 23
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 28 · 2023: 17 · 2022: 30 · 2021: 19 · 2020: 29 · 2019: 43 · 2018: 30 · 2017: 23 · 2016: 22 · 2015: 16 · 2014: 23 · 2013: 22 · 2012: 8
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- lithium response, bipolar disorder, family transmission, genetic susceptibility, long-term lithium therapy, treatment response
- MeSH terms
- Adult, Bipolar Disorder, Child, Dose-Response Relationship, Drug, Drug Administration Schedule, Family, Female, Humans, Lithium, Male, Middle Aged, Pharmacogenetics, Psychiatric Status Rating Scales, Retrospective Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.